Cargando…
Develop and Validate a Risk Score in Predicting Renal Failure in Focal Segmental Glomerulosclerosis
INTRODUCTION: The aim of this study was to develop and validate a risk score (RS) for end-stage kidney disease (ESKD) in patients with focal segmental glomerulosclerosis (FSGS). METHODS: Patient with biopsy-proven FSGS was enrolled. All the patients were allocated 1:1 to the two groups according to...
Autores principales: | Cai, Yikai, Liu, Yunzi, Tong, Jun, Jin, Yuanmeng, Liu, Jian, Hao, Xu, Ji, Yinhong, Ma, Jun, Pan, Xiaoxia, Chen, Nan, Ren, Hong, Xie, Jingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601954/ https://www.ncbi.nlm.nih.gov/pubmed/37899999 http://dx.doi.org/10.1159/000529773 |
Ejemplares similares
-
New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease
por: Weng, Qinjie, et al.
Publicado: (2020) -
Mutation in XPO5 causes adult-onset autosomal dominant familial focal segmental glomerulosclerosis
por: Hussain, Hafiz Muhammad Jafar, et al.
Publicado: (2022) -
Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis
por: Liu, Jian, et al.
Publicado: (2017) -
Rituximab treatment in adults with refractory minimal change disease or focal segmental glomerulosclerosis
por: Ren, Hong, et al.
Publicado: (2017) -
Distinct Metabolic Profile of Primary Focal Segmental Glomerulosclerosis Revealed by NMR-Based Metabolomics
por: Hao, Xu, et al.
Publicado: (2013)